Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 175,907 | 209,996 | 179,627 | 172,139 | 141,037 |
| Cost of Goods | 84,814 | 96,267 | 82,882 | 79,685 | 67,750 |
| Gross Profit | 91,093 | 113,729 | 96,745 | 92,454 | 73,287 |
| Operating Expenses | 107,245 | 101,258 | 89,907 | 87,707 | 77,274 |
| Operating Income | -15,338 | 12,738 | 7,720 | 5,432 | -3,237 |
| Interest Expense | 1,516 | 1,514 | 1,511 | 1,509 | 1,506 |
| Other Income | 415 | -79 | -361 | 146 | -418 |
| Pre-tax Income | -16,439 | 11,145 | 5,848 | 4,069 | -5,161 |
| Income Tax | -1,724 | 337 | 54 | 61 | -117 |
| Net Income Continuous | -14,715 | 10,808 | 5,794 | 4,008 | -5,044 |
| Net Income | $-14,715 | $10,808 | $5,794 | $4,008 | $-5,044 |
| EPS Basic Total Ops | -0.23 | 0.18 | 0.09 | 0.06 | -0.08 |
| EPS Basic Continuous Ops | -0.23 | 0.17 | 0.09 | 0.06 | -0.08 |
| EPS Diluted Total Ops | -0.23 | 0.17 | 0.09 | 0.06 | -0.08 |
| EPS Diluted Continuous Ops | -0.23 | 0.17 | 0.09 | 0.06 | -0.08 |
| EBITDA(a) | $-10,710 | $17,141 | $11,776 | $8,788 | $885 |